AzTrials
AzTrials

Diabetes MellitusNCT06465771

Feasibility of a Youth-led NCD Risk Reduction Initiative in Selected Schools of Slums in Karachi, Pakistan: a Mixed-methods, pre-and Post-intervention Study

A study testing Youth-led NCD risk reduction intervention in people with Diabetes Mellitus and Cardiovascular Diseases, run by Aga Khan University.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The study will occur in ten selected schools within Azam Basti and Mehmoodabad, organized into five sequential phases. Phase I involves identifying NCD modifiable risk factors among younger peers (Classes 5 and 6 students) using structured diaries. Read more about this study

Who is it for?
Ages 9 to 16 yearsHealthy volunteers can take part
Conditions the study is for
Diabetes Mellitus, Cardiovascular Diseases, Cancer
What is being tested?
Youth-led NCD risk reduction intervention
Could I receive a placebo?
No, everyone receives an active treatment
How many people
40 participants
Where
No sites listed yet
Study dates
Aug 2024to 31 Aug 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 9 to 16 years
  • All sexes
  • Healthy volunteers accepted
  • Child

Who may be able to join

  • Both government and private schools
  • Schools that have classes 1 to 10 in one boundary
  • Schools who agree to take part in the qualitative interviews
  • Schools that permit to engage youth, their parents, and younger peers in the study for ten months
  • For youth: Students of classes 9 and 10 (aged 14 to 16 years)
  • For younger peers: Students of classes 5 and 6 (9 to 12 years)
  • Students who provide written informed assent followed by parental consent
  • Parents of youth and other stakeholders, including head teachers, schoolteachers, and canteen staff who provide written informed consent

Who cannot join

  • Schools currently enrolled in any NCD-related intervention program or any similar program during the last six months
  • For youth: Having any severe or chronic medical condition or disability that restricts active participation of students in the intervention co-creation and delivery

Trial locations and contacts

No sites are listed yet.

About this study

The study will occur in ten selected schools within Azam Basti and Mehmoodabad, organized into five sequential phases. Phase I involves identifying NCD modifiable risk factors among younger peers (Classes 5 and 6 students) using structured diaries. Phase II includes qualitative interviews with youth (Classes 9 and 10 students), parents, and stakeholders to discuss intervention material and delivery. Phase III comprises a one-day workshop to co-create an intervention. Phase IV involves three-day training for youth to understand and deliver the intervention to their peers. Finally, Phase V assesses the intervention's feasibility using a pre-and post-test design approach.

Being tested
Youth-led NCD risk reduction intervention
Medical subject headings
Diabetes Mellitus, Cardiovascular Diseases, Neoplasms, Lung Diseases

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Youth-led NCD risk reduction interventionBehavioural

    With the help of Youth (students of grades 9 and 10), their parents and other stakeholders, including teachers, headteachers, and canteen staff through qualitative interviews, we will develop an intervention focuses on NCD risk reduction among younger peers (students of grades 5 and 6). A nutritionist will train the youth on how to deliver the intervention among their younger peers.

Study groups in NCT06465771
Study groupRoleWhat they receive
Youth-led NCD risk reduction initiativeExperimentalStudents of grades 5 and 6 will receive NCD risk reduction intervention from youth (students of grades 9 and 10). The shared risk factors will include unhealthy diet, physical activity, and tobacco use. The NCDs will cover diabetes, cardiovascular disease, hypertension, and cancers.
Receives: Behavioral: Youth-led NCD risk reduction intervention

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. The compliance of delivering the intervention in schools using a fidelity checklist

    Once the intervention will be finalized, a fidelity checklist will be developed and used to assess adherence to the intervention delivery. It will be reported as if the intervention is delivered completely, partially, or incomplete based on each component of the intervention

    Measured: Three months

  2. The recruitment and attrition rates for schools and children

    The recruitment and attrition rates will be assessed by reporting the frequencies and percentages of schools and children (youth and younger peer) enrolled and retained in the study.

    Measured: Ten months

  3. The rate for completing the structured diaries for diet, physical activity, and tobacco use at pre-and post-intervention assessments

    The frequencies and percentages of children completing the structured diaries for diet, physical activity, and tobacco use at pre-and post-intervention assessments will be reported.

    Measured: Ten months

  4. The change in the frequency and percentages of risk factors, including unhealthy diet, physical inactivity, and tobacco use at post-intervention compared to the baseline using a structured diary

    The change in the frequency and percentages of risk factors, including unhealthy diet, physical inactivity, and tobacco use at post-intervention compared to the baseline will be reported. The information will be collected through structured diaries at baseline and after the intervention is delivered. The students will complete the diary for four days before and after the intervention.

    Measured: Ten months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted20 Jun 2024
  2. Study startAug 2024 (estimated)
  3. Primary completion31 Aug 2025 (estimated)
  4. Study completion31 Aug 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
40 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06465771
Sponsor's protocol ID
9763
Status last verified
Jun 2024
First submitted
27 May 2024
Last updated
20 Jun 2024
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Publications

  • Naz S, Ilyas M, Iqbal R. Feasibility of co-creating and delivering a youth-led noncommunicable diseases risk reduction intervention in schools of slums in Karachi, Pakistan: protocol for a mixed-methods, pre- and post-intervention study. Pilot Feasibility Stud. 2025 Jun 2;11(1):76. doi: 10.1186/s40814-025-01662-0.

    PubMed 40457417

Questions about this trial

What is this clinical trial studying?

A study testing Youth-led NCD risk reduction intervention in people with Diabetes Mellitus and Cardiovascular Diseases, run by Aga Khan University.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 8 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 20 Jun 2024. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Sabahat Naz (03362293099, sabahat.naz1@aku.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

The compliance of delivering the intervention in schools using a fidelity checklist (time frame: Three months). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT06465771, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 20 Jun 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in